-
ICD-10-CM Codes
›
-
G00-G99
›
-
G70-G73
›
-
G70-
›
-
2023 ICD-10-CM Diagnosis Code G70.0
2023 ICD-10-CM Diagnosis Code G70.0
Myasthenia gravis
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- G70.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2023 edition of ICD-10-CM G70.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of G70.0 - other international versions of ICD-10 G70.0 may differ.
The following code(s) above
G70.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
G70.0:
Clinical Information
- A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness. It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.
- A disease in which antibodies made by a person's immune system prevent certain nerve-muscle interactions. It causes weakness in the arms and legs, vision problems, and drooping eyelids or head. It may also cause paralysis and problems with swallowing, talking, climbing stairs, lifting things, and getting up from a sitting position. The muscle weakness gets worse during activity, and improves after periods of rest.
- A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the neuromuscular junction, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. Thymoma is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)
- Disease characterized by progressive weakness and exhaustibility of voluntary muscles without atrophy or sensory disturbance and caused by an autoimmune attack on acetylcholine receptors at the neuromuscular junction.
- Myasthenia gravis is disease that causes weakness in the muscles under your control. It happens because of a problem in communication between your nerves and muscles. Myasthenia gravis is an autoimmune disease. Your body's own immune system makes antibodies that block or change some of the nerve signals to your muscles. This makes your muscles weaker.common symptoms are trouble with eye and eyelid movement, facial expression and swallowing. But it can also affect other muscles. The weakness gets worse with activity, and better with rest..there are medicines to help improve nerve-to-muscle messages and make muscles stronger. With treatment, the muscle weakness often gets much better. Other drugs keep your body from making so many abnormal antibodies. There are also treatments which filter abnormal antibodies from the blood or add healthy antibodies from donated blood. Sometimes surgery to take out the thymus gland helps.for some people, myasthenia gravis can go into remission and they do not need medicines. The remission can be temporary or permanent.if you have myasthenia gravis, it is important to follow your treatment plan. If you do, you can expect your life to be normal or close to it.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to G70.0:
ICD-10-CM Codes Adjacent To G70.0
G62.82 Radiation-induced polyneuropathy
G62.89 Other specified polyneuropathies
G62.9 Polyneuropathy, unspecified
G63 Polyneuropathy in diseases classified elsewhere
G64 Other disorders of peripheral nervous system
G65 Sequelae of inflammatory and toxic polyneuropathies
G65.0 Sequelae of Guillain-Barré syndrome
G65.1 Sequelae of other inflammatory polyneuropathy
G65.2 Sequelae of toxic polyneuropathy
G70 Myasthenia gravis and other myoneural disorders
G70.0
Myasthenia gravis
G70.00 …… without (acute) exacerbation
G70.01 …… with (acute) exacerbation
G70.1 Toxic myoneural disorders
G70.2 Congenital and developmental myasthenia
G70.8 Other specified myoneural disorders
G70.80 Lambert-Eaton syndrome, unspecified
G70.81 Lambert-Eaton syndrome in disease classified elsewhere
G70.89 Other specified myoneural disorders
G70.9 Myoneural disorder, unspecified
G71 Primary disorders of muscles
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.